News|Articles|September 2, 2003

Pharmaceutical Technology

  • Pharmaceutical Technology-09-02-2003
  • Volume 27
  • Issue 9

Counterfeiting, Compliance, and Controls

Author(s)Jill Wechsler

FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.
External Link - article-70112.pdf

Articles in this issue

over 22 years ago

September 2003

over 22 years ago

In the Spotlight September 2003

over 22 years ago

September 2003

over 22 years ago

The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride

over 22 years ago

Disposable Filtration Lightens Cleaning and Validation Load

over 22 years ago

CROs Hoping for Research Burst in Second Half of 2003

over 22 years ago

Positron Emission Particle Tracking Studies of a Wurster Process for Coating Applications

over 22 years ago

Improved Blister Packaging Benefits Consumers, Caregivers, and Drug Makers

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content